Garry Lund

630 total citations
21 papers, 501 citations indexed

About

Garry Lund is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Garry Lund has authored 21 papers receiving a total of 501 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 7 papers in Hepatology and 6 papers in Molecular Biology. Recurrent topics in Garry Lund's work include Virology and Viral Diseases (9 papers), Hepatitis C virus research (6 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). Garry Lund is often cited by papers focused on Virology and Viral Diseases (9 papers), Hepatitis C virus research (6 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). Garry Lund collaborates with scholars based in Canada, Finland and United States. Garry Lund's co-authors include A. Salmi, Norman M. Kneteman, D. Lorne Tyrrell, Douglas G. Scraba, Barry Ziola, Donna N. Douglas, Jamie Lewis, Yutaka Takebe, Carrie J. Saucedo and Takaji Wakita and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Hepatology.

In The Last Decade

Garry Lund

20 papers receiving 470 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Garry Lund Canada 12 232 152 122 75 69 21 501
Jennifer Molle France 11 251 1.1× 275 1.8× 105 0.9× 68 0.9× 77 1.1× 26 701
Zhenghui Wu China 12 213 0.9× 120 0.8× 185 1.5× 301 4.0× 25 0.4× 20 732
Richard H. Decker United States 13 373 1.6× 411 2.7× 72 0.6× 121 1.6× 24 0.3× 22 625
C J Chen Taiwan 6 144 0.6× 77 0.5× 242 2.0× 153 2.0× 9 0.1× 9 641
Mami Matsuda Japan 20 401 1.7× 385 2.5× 363 3.0× 230 3.1× 47 0.7× 42 1.1k
О. В. Масалова Russia 11 246 1.1× 138 0.9× 164 1.3× 60 0.8× 36 0.5× 41 429
Marion Poenisch Germany 10 216 0.9× 146 1.0× 88 0.7× 100 1.3× 8 0.1× 11 404
A Bingen France 13 200 0.9× 164 1.1× 98 0.8× 45 0.6× 17 0.2× 34 466
K Konno Japan 11 387 1.7× 73 0.5× 144 1.2× 190 2.5× 10 0.1× 23 591
Peter Oudshoorn Netherlands 14 159 0.7× 80 0.5× 318 2.6× 106 1.4× 83 1.2× 21 594

Countries citing papers authored by Garry Lund

Since Specialization
Citations

This map shows the geographic impact of Garry Lund's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Garry Lund with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Garry Lund more than expected).

Fields of papers citing papers by Garry Lund

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Garry Lund. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Garry Lund. The network helps show where Garry Lund may publish in the future.

Co-authorship network of co-authors of Garry Lund

This figure shows the co-authorship network connecting the top 25 collaborators of Garry Lund. A scholar is included among the top collaborators of Garry Lund based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Garry Lund. Garry Lund is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Douglas, Donna N., Jamie T. Lewis, Rakesh Bhat, et al.. (2015). Oxidative Stress Attenuates Lipid Synthesis and Increases Mitochondrial Fatty Acid Oxidation in Hepatoma Cells Infected with Hepatitis C Virus. Journal of Biological Chemistry. 291(4). 1974–1990. 39 indexed citations
2.
Takebe, Yutaka, Carrie J. Saucedo, Garry Lund, et al.. (2013). Antiviral Lectins from Red and Blue-Green Algae Show Potent In Vitro and In Vivo Activity against Hepatitis C Virus. PLoS ONE. 8(5). e64449–e64449. 107 indexed citations
3.
Foster, John R., et al.. (2013). Chimeric rodents with humanized liver: bridging the preclinical/clinical trial gap in ADME/toxicity studies. Xenobiotica. 44(2). 109–122. 28 indexed citations
4.
Takebe, Yutaka, Garry Lund, Rie Uenishi, et al.. (2012). Antiviral lectins from red and blue-green algae show potent in vitro and in vivo activity against Hepatitis C virus. Planta Medica. 78(11).
5.
Kneteman, Norman M., et al.. (2011). Impact of Calcineurin Inhibitors With or Without Interferon on Hepatitis C Virus Titers in a Chimeric Mouse Model of Hepatitis C Virus Infection. Liver Transplantation. 18(1). 38–44. 8 indexed citations
6.
Kawahara, Toshiyasu, Christian Toso, Donna N. Douglas, et al.. (2010). Factors affecting hepatocyte isolation, engraftment, and replication in an in vivo model. Liver Transplantation. 16(8). 974–982. 38 indexed citations
7.
Kawahara, Toshiyasu, Donna N. Douglas, Jamie Lewis, et al.. (2010). Critical role of natural killer cells in the rejection of human hepatocytes after xenotransplantation into immunodeficient mice. Transplant International. 19 indexed citations
8.
Steenbergen, Renske D.M., Michael Joyce, Garry Lund, et al.. (2010). Lipoprotein profiles in SCID/uPA mice transplanted with human hepatocytes become human-like and correlate with HCV infection success. American Journal of Physiology-Gastrointestinal and Liver Physiology. 299(4). G844–G854. 30 indexed citations
9.
Mäkelä, Mika J., Richard H. Smith, Garry Lund, & A. Salmi. (1989). T‐Cell Recognition of Measles Virus Haemagglutinin Studied in a Mouse Model. Scandinavian Journal of Immunology. 29(5). 597–607. 4 indexed citations
10.
Lund, Garry, et al.. (1989). Antigenicity of the Measles Virus Haemagglutinin Studied by Using Synthetic Peptides. Journal of General Virology. 70(3). 603–614. 33 indexed citations
11.
Salmi, A., Garry Lund, Barry Ziola, & Mauri Reunanen. (1986). Circulating immune complexes in patients with subacute sclerosing panencephalitis. Clinical Immunology and Immunopathology. 41(1). 16–25. 2 indexed citations
12.
Lund, Garry, D. Lorne Tyrrell, Roger Bradley, & Douglas G. Scraba. (1984). The Molecular Length of Measles Virus RNA and the Structural Organization of Measles Nucleocapsids. Journal of General Virology. 65(9). 1535–1542. 29 indexed citations
13.
Salmi, A. & Garry Lund. (1984). Immunoassays for Measles Virus Nucleocapsid Antigen: Effect of Antigen-Antibody Complexes. Journal of General Virology. 65(10). 1655–1663. 4 indexed citations
14.
Lund, Garry, et al.. (1983). Characterization of immune complexes in multiple sclerosis by an antigen-specific immune complex radioimmunoassay. Journal of Neuroimmunology. 4(3). 253–264. 8 indexed citations
15.
Ziola, Barry, Garry Lund, Olli Meurman, & A. Salmi. (1983). Circulating immune complexes in patients with acute measles and rubella virus infections. Infection and Immunity. 41(2). 578–583. 11 indexed citations
16.
Kekomäki, R., et al.. (1982). Circulating immune complexes in patients with multiple sclerosis. Journal of the Neurological Sciences. 55(3). 273–283. 13 indexed citations
17.
Lund, Garry & A. Salmi. (1982). Radioimmunoassay of measles virus hemagglutinin protein G. Journal of Virological Methods. 4(6). 331–341. 3 indexed citations
18.
Lund, Garry & A. Salmi. (1981). Purification and Characterization of Measles Virus Haemagglutinin Protein G. Journal of General Virology. 56(1). 185–193. 14 indexed citations
19.
20.
Lund, Garry, Barry Ziola, A. Salmi, & Douglas G. Scraba. (1977). Structure of the mengo virion V. Distribution of the capsid polypeptides with respect to the surface of the virus particle. Virology. 78(1). 35–44. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jennifer Molle Breakdown of academic impact, for papers by Zhenghui Wu Breakdown of academic impact, for papers by Richard H. Decker Breakdown of academic impact, for papers by C J Chen Breakdown of academic impact, for papers by Mami Matsuda Breakdown of academic impact, for papers by О. В. Масалова Breakdown of academic impact, for papers by Marion Poenisch Breakdown of academic impact, for papers by A Bingen Breakdown of academic impact, for papers by K Konno Breakdown of academic impact, for papers by Peter Oudshoorn
Rankless by CCL
2026